886365-06-6 Usage
General Description
5-Bromo-4-methyl-pyridine-2-carboxylic acid methyl ester is a chemical compound with the molecular formula C8H8BrNO2. It is a methyl ester derivative of 5-bromo-4-methyl-2-pyridinecarboxylic acid and is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. 5-Bromo-4-methyl-pyridine-2-carboxylic acid methyl ester is a white to off-white solid with a molecular weight of 227.06 g/mol. It is primarily used as a building block in organic synthesis and has potential applications in the pharmaceutical industry for the production of new drug compounds. Additionally, it may also have uses in the development of agrochemicals and other specialty chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 886365-06-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,6,3,6 and 5 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 886365-06:
(8*8)+(7*8)+(6*6)+(5*3)+(4*6)+(3*5)+(2*0)+(1*6)=216
216 % 10 = 6
So 886365-06-6 is a valid CAS Registry Number.
InChI:InChI=1/C7H6BrNO2/c1-4-2-6(7(10)11)9-3-5(4)8/h2-3H,1H3,(H,10,11)
886365-06-6Relevant articles and documents
DIAZAINDOLE INHIBITORS OF CRAC
-
Paragraph 0135, (2013/06/28)
Disclosed are compounds of Formula (I): useful for treatment of autoimmune and inflammatory diseases associated with IL-2 inhibition via modulation of calcium release-activated calcium (CRAC) channels. Also disclosed are methods of making and using the compounds for treatment of diseases associated with CRAC channels.
4-AZAINDOLE INHIBITORS OF CRAC
-
Paragraph 0135, (2013/06/28)
Disclosed are compounds of Formula (I): useful for treatment of autoimmune and inflammatory diseases associated with IL-2 inhibition via modulation of calcium release-activated calcium (CRAC) channels. Also disclosed are methods of making and using the compounds for treatment of diseases associated with CRAC channels.
INDOLE DERIVATIVES AS CRAC MODULATORS
-
Page/Page column 34, (2012/01/30)
Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein R1, R2, R3 and R4 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with calcium release-activated calcium channels (CRAC).